mbiomics: Funding, Investors & Team (Sep 2026)
Mbiomics is a company in the field of biotechnology.
mbiomics has raised $26.2M across 2 funding rounds on record, the most recent a Series A of $12.0M announced in Apr 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
mbiomics Company Profile and Key Stats
Latest funding round on record: Apr 2026.
mbiomics Funding Rounds
mbiomics raised $14.2M in a Series A announced in Mar 2023.
3.1 years later, a Series A of $12.0M was announced in Apr 2026.
mbiomics Founders and Leadership Team
Contact details for the mbiomics team: 1 of 2 have an email address on file.
Start 14-day free trial →mbiomics Funding Compared to Other Biotechnology Startups
mbiomics' latest round of $12.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like mbiomics in Biotechnology and Munich
Companies Similar to mbiomics
Computomics applies AI to bioinformatics data to enable rapid understanding of genomics and drive advanced…
smartbax develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug…
Pacifico Biolabs offers fermentation biotechnology for development, production and distribution of…
NanoStruct is a biotechnology company that develops nanostructured sensor chips to identify bacteria and…
Tacalyx, a company originating from Max-Planck-Institute of Colloids and Interfaces in Potsdam, Germany, is…
Primogene is a biotechnology company that provides ingredient development, bioprocess manufacturing, and…
At EVANIUM, we make plant compounds like polyphenols and flavonoids more effective by improving their…
Picea Biosolutions is a biotechnology firm. Based on their core platform technology, they develop tailored…
KUPANDO is a pioneering biopharmaceutical firm that is developing TLR 4/7 agonists to boost innate immunity.…
iDEL Therapeutics is advancing a new class of cancer medicines by delivering therapeutic payloads directly…
mbiomics Funding FAQs
What does mbiomics do?
Mbiomics is a company in the field of biotechnology.
How much funding has mbiomics raised?
mbiomics has raised $26.2M across 2 rounds on record. The most recent is a Series A of $12.0M announced in Apr 2026.
When did mbiomics last raise funding?
mbiomics' most recent funding round on record is a Series A of $12.0M, announced in Apr 2026.
Who founded mbiomics?
FundedIQ lists Johannes B (Founder), Markus Rinecker (Founder) at mbiomics.
Where is mbiomics headquartered?
mbiomics is based in Munich, Bayern, Germany.
How many employees does mbiomics have?
mbiomics is in the 1-10 employee band.
How does mbiomics' funding compare to other Biotechnology startups?
mbiomics' latest round of $12.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's mbiomics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for mbiomics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.